Literature DB >> 8400467

Experimental aspects of spinal cord regeneration.

M E Schwab1.   

Abstract

Sprouting, elongation, and functional reconnection are the necessary steps for successful regeneration of lesioned axons. Induction of growth-specific proteins in adult cells and of lesioned fibers sprouting can occur spontaneously in central nervous system neurons and may be enhanced by specific neurotrophic factors. The extremely limited elongation commonly observed in the adult central nervous system depends crucially on the presence of neurite growth-inhibitory molecules, such as those associated with central nervous system myelin or several candidate molecules expressed in glial scars. Optic nerve axons guided into their targets by peripheral nerve bridges were able to restore functional synapses in adult rats, showing that the relevant recognition mechanisms are present. Important steps in the cellular and molecular understanding of these basic processes of lesioned axon regeneration are being taken at present and significant progress can be expected in the near future.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400467

Source DB:  PubMed          Journal:  Curr Opin Neurol Neurosurg        ISSN: 0951-7383


  2 in total

1.  Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons.

Authors:  Dongming Cai; Minghao Zhong; Runsheng Wang; William J Netzer; Dennis Shields; Hui Zheng; Sangram S Sisodia; David A Foster; Fred S Gorelick; Huaxi Xu; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

2.  Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.

Authors:  Laurie A Robak; Karthik Venkatesh; Hakjoo Lee; Stephen J Raiker; Yuntao Duan; Jane Lee-Osbourne; Thomas Hofer; Rose G Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.